Provided by Tiger Trade Technology Pte. Ltd.

Jasper Therapeutics

0.5800
-0.0454-7.26%
Post-market: 0.5784-0.0016-0.28%19:59 EDT
Volume:540.20K
Turnover:328.52K
Market Cap:19.30M
PE:-0.62
High:0.6546
Open:0.6200
Low:0.5721
Close:0.6254
52wk High:2.69
52wk Low:0.3151
Shares:33.27M
Float Shares:30.00M
Volume Ratio:1.13
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-3.9545
ROE:-255.05%
ROA:-113.41%
PB:13.66
PE(LYR):-0.15

Loading ...

Jasper Therapeutics Halts Briquilimab Extension Study in Chronic Urticaria: What Investors Should Know

TIPRANKS
·
Aug 07

JSPR Completes Briquilimab Trial In Chronic Hives, Setting Up Next Risk–Reward Catalyst

TIPRANKS
·
Aug 07

Jasper Therapeutics Shareholders Back Board, Auditors, Pay Plan

TIPRANKS
·
Aug 04

Jasper Therapeutics Holds Annual Stockholders Meeting; 75% of Shares Represented

Reuters
·
Aug 04

Jasper Therapeutics COO Matthew E. Ros Files Initial Beneficial Ownership Statement

Reuters
·
Jul 23

Jasper Therapeutics Director Patrick J. Crutcher Files Initial Beneficial Ownership Statement

Reuters
·
Jul 21

Jasper Therapeutics Completes Kira Acquisition and PIPE Financing

TIPRANKS
·
Jul 17

Jasper Therapeutics Posts Investor Presentation on Kira Merger, PIPE Financing and Immunology Pipeline Strategy

Reuters
·
Jul 17

Jasper Therapeutics Completes Acquisition of Kira Pharmaceuticals in All-stock Deal

Reuters
·
Jul 17

Jasper Therapeutics - Announces $132 Mln Private Placement of Convertible Preferred Stock

THOMSON REUTERS
·
Jul 17

Jasper Therapeutics Announces Merger with Kira Pharmaceuticals

THOMSON REUTERS
·
Jul 17

Jasper Therapeutics - Combined Company Operations Expected to be Funded Through Second Half of 2028

THOMSON REUTERS
·
Jul 17

Jasper Therapeutics trading halted, news pending

TIPRANKS
·
Jul 17

NASDAQ Trade Halt Halt News Pending at 05:10 Pm

Reuters
·
Jul 17

Insider Traders Lose US$287k As Jasper Therapeutics Drops

Simply Wall St.
·
Jun 30

Jasper Therapeutics announces annual shareholder meeting

Reuters
·
Jun 16

Jasper Therapeutics - on June 3, 2026, Co Receives Nasdaq Notice for Minimum Bid Price Non-Compliance - SEC Filing

THOMSON REUTERS
·
Jun 10

Jasper Therapeutics gets Nasdaq notice after shares trade below $1 bid-price minimum

Reuters
·
Jun 10

Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate

Benzinga
·
Jun 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jasper Therapeutics (JSPR) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Jun 02